Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.
about
Stable isotope-resolved metabolomics and applications for drug developmentPrinciples and applications of liquid chromatography-mass spectrometry in clinical biochemistryPharmacokinetic Studies of Chinese Medicinal Herbs Using an Automated Blood Sampling System and Liquid Chromatography-mass SpectrometryPost-acquisition filtering of salt cluster artefacts for LC-MS based human metabolomic studiesBiological Matrix Effects in Quantitative Tandem Mass Spectrometry-Based Analytical Methods: Advancing BiomonitoringAn UPLC-MS/MS method for highly sensitive high-throughput analysis of phytohormones in plant tissues.Metabolome analysis of biosynthetic mutants reveals a diversity of metabolic changes and allows identification of a large number of new compounds in Arabidopsis.UPLC-MS/MS determination of ptaquiloside and pterosin B in preserved natural water.Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis.MALDI-TOF MS as a label-free approach to rapid inhibitor screening.Comparison of matrix effects in HPLC-MS/MS and UPLC-MS/MS analysis of nine basic pharmaceuticals in surface waters.A rapid, sensitive and selective liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry method for determination of fenretinide (4-HPR) in plasmaElectron ionization in LC-MS: recent developments and applications of the direct-EI LC-MS interface.Direct-EI in LC-MS: towards a universal detector for small-molecule applications.An overview of matrix effects in liquid chromatography-mass spectrometry.A discharge adaptor interface for use in liquid chromatography/mass spectrometry.Determination of isotoosendanin in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetics study.Direct Mass Spectrometry Analysis of Untreated Samples of Ultralow Amounts Using Extraction Nano-Electrospray.Ionization suppression effects with condensed phase membrane introduction mass spectrometry: methods to increase the linear dynamic range and sensitivity.A Method for LC-MS/MS Profiling of Coumarins in Zanthoxylum zanthoxyloides (Lam.) B. Zepernich and Timler Extracts and Essential Oils.An improved LC-MS/MS method for quantitative determination of ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic studyQuantitative analysis of nine coumarins in rat urine and bile after oral administration of Radix Glehniae extract by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.Critical topics in ensuring data quality in bioanalytical LC-MS method development.Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's DiseaseHolistic management of DSD.Methodology for determining major constituents of ayahuasca and their metabolites in blood.A clinical assay for the measurement of milrinone in plasma by HPLC mass spectrometry.Determination of enalapril and enalaprilat in small human serum quantities for pediatric trials by HPLC-tandem mass spectrometry.Analysis of androgenic steroids in environmental waters by large-volume injection liquid chromatography tandem mass spectrometry.Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA.Liquid chromatography-mass spectrometry method for the analysis of 1,4-dimethylpyridinium in rat plasma--application to pharmacokinetic studies.Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanupTurbulent flow chromatography in bioanalysis: a review.Determination of cnidilin and its two metabolites in rat bile and stool after oral administration by HPLC/electrospray ionization tandem mass spectrometry.Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.Application of screening experimental designs to assess chromatographic isotope effect upon isotope-coded derivatization for quantitative liquid chromatography-mass spectrometry.Determination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trials.Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of urapidil and aripiprazole in human plasma and its application to human pharmacokinetic study.Simultaneous quantitation of amino acid mixtures using clustering agents.
P2860
Q24629149-B1B2B5B4-ACFC-43DD-BDF4-D7C024C2C818Q24653004-184E2118-D92F-4686-9218-6F38F1CC4409Q27006864-2BF31A89-FB61-4F31-A271-BD24E1C0B320Q27902273-473BBF04-98E7-45BA-840F-21DA5E5AAFADQ28082483-004474E7-4223-4317-AF21-3825A0743A7DQ30317951-A3EBB1CC-802B-4936-9BDD-A456D822400CQ30319518-36DEF749-63C1-44C1-B42B-D84D3EDC8593Q31126465-A1C27883-8E04-4C50-95C6-F15C9017F642Q31135042-FF800F90-E3D9-49AA-893D-E53D256BA33EQ33240007-50EC4433-15BA-43C1-9277-CAA7F4579C91Q33324046-BD6202B4-4132-4574-BC7D-414A09B7A58BQ33438627-1D941F6A-E235-4947-9A48-3985A0E4EA06Q33449127-852338BB-AB07-401F-9CB9-03269E7AC1E2Q33449684-88339A45-BA15-4181-91D6-9D1FA04FB9AAQ33450184-EAD385A8-2648-4F10-955C-992D08E2C215Q33454070-1B023E30-A6A6-458E-B1AE-4A6027D1E012Q33455262-096C507C-FDA7-48D6-9987-5AF4F364237AQ33460204-B3CE87C7-752E-4BDC-81E4-0F237C6BAE9BQ33464515-54D66468-3A1D-42C5-A4C1-4CF1A306BF64Q33469674-3D8037F4-6CA0-46D2-A3F0-D12A2E874C65Q33554953-D13BF2A9-4D10-44B0-8507-A83B20DFDE99Q33705591-967B5305-419A-44EF-9E24-B994D2A1E532Q33740814-3F1685E5-14B5-4CBF-91EB-06DACB89C43AQ33748874-B2F7A7BA-1224-49B7-972D-F65F2B4C3522Q33844949-E99F947F-030F-466C-953C-867DA8C5744EQ33943383-C0D3D143-BEEE-4AE9-9049-1740373CEF62Q33944518-51C5BB53-DEA3-407F-99A1-F44A7B2582E0Q34014658-CA5128F0-2517-4352-9711-FCADE92BD883Q34033336-CD7FF2B3-B2DC-421B-89D4-ADBE97146A12Q34082106-24E8BAD9-46D8-485D-9091-C21DBB15C027Q34124314-57B8BD4B-D7F3-4269-9D63-4A5C763AFC7DQ34253226-63E87A8F-3B0B-415B-BA94-3087C84837CEQ34284645-5A2A1367-3CE3-4ADA-9D8B-6C97D65C607AQ34317104-7C7C60F5-A6F8-4B34-BA7A-178E9DC48AEFQ34423492-215AFEDB-9875-470E-81F0-FB97752956A1Q34433289-A6C25A4B-C25F-4EB5-8D52-CDA6287B3BA9Q34434064-538FC9A4-7880-4A07-A02F-1BB679C4E4BDQ34440479-106E0333-919F-433A-BDAB-39734B1EE888Q34609625-B94864B3-0028-4E69-A8D6-7B80EF2EC0C5Q34709583-363D9713-0330-40D1-A62C-F2E9C78E3BC4
P2860
Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Matrix effects: the Achilles h ...... pray-tandem mass spectrometry.
@ast
Matrix effects: the Achilles h ...... pray-tandem mass spectrometry.
@en
type
label
Matrix effects: the Achilles h ...... pray-tandem mass spectrometry.
@ast
Matrix effects: the Achilles h ...... pray-tandem mass spectrometry.
@en
prefLabel
Matrix effects: the Achilles h ...... pray-tandem mass spectrometry.
@ast
Matrix effects: the Achilles h ...... pray-tandem mass spectrometry.
@en
P1476
Matrix effects: the Achilles h ...... pray-tandem mass spectrometry.
@en
P2093
Paul J Taylor
P304
P356
10.1016/J.CLINBIOCHEM.2004.11.007
P577
2005-04-01T00:00:00Z